Search

Search Results

• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7644

  PDF: 2829
• 

  Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

  O. Di Munno, A. Delle Sedie

  67-79

  https://doi.org/10.4081/reumatismo.2011.67

  1816

  PDF: 1084
• 

  Glucocorticoid-induced osteoporosis: 2013 update

  M. Mazzantini, O. Di Munno

  144-152

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.787

  3937

  PDF: 2374

• PO:20:014 | Post-partum osteoporosis: severe clinical presentation in absence of known risk factors Domenico Birra¹, Ludovica Frances Grasso², Vittoria Gammaldi¹, Antonietta De Sena¹, Carmine Pio Petrosino², Rosalia Boccia², Gabriella Oliva¹, Vincenzo Nuzzo¹ | ¹Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; ²Istituto Superiore di Sanità, Roma

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2178

  205

• Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy

  M. Rossini, F.P. Cantatore, A. Del Puente, B. Frediani, D. Gatti, S. Giannini, M. Varenna, O. Viapiana, G.D. Sebastiani

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1696

  3876

  PDF: 1640
• 

  Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life

  G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio

  71-74

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1267

  2009

  PDF: 1344